Michael Nedelcovych
Stock Analyst at TD Cowen
(1.05)
# 3,880
Out of 5,074 analysts
94
Total ratings
44.9%
Success rate
-2%
Average return
Main Sectors:
Stocks Rated by Michael Nedelcovych
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Rated: Buy | $300 | $267.61 | +12.10% | 4 | Oct 19, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Reiterated: Buy | ¥6,550 → ¥3,590 | ¥2,801 | +28.17% | 2 | Sep 28, 2026 | |
| NVO Novo Nordisk | Reiterated: Hold | $42 | $39.43 | +6.52% | 32 | Sep 22, 2026 | |
| RPRX Royalty Pharma | Rated: Buy | $65 → $68 | $63.75 | +6.67% | 11 | Sep 8, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $40.00 | $32.98 | +21.29% | 1 | Jul 6, 2026 | |
| TAK Takeda Pharmaceutical Company | Reiterated: Buy | $21 | $20.36 | +3.14% | 14 | Jun 4, 2026 | |
| CHRS Coherus Oncology | Reiterated: Buy | n/a | $1.05 | - | 13 | May 28, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Hold | $9.95 | $9.09 | +9.46% | 9 | Apr 30, 2026 | |
| SWX: MOLN Molecular Partners AG | Reiterated: Buy | CHF 15.00 | CHF 3.03 | +395.05% | 6 | Mar 16, 2026 | |
| TYO: 4502 Takeda Pharmaceutical Company Limited | Reiterated: Buy | ¥5,135 | ¥6,364 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.61 | n/a | 1 | Mar 14, 2025 |
Johnson & Johnson
Oct 19, 2026
Rated: Buy
Price Target: $300
Current: $267.61
Upside: +12.10%
Daiichi Sankyo Company, Limited
Sep 28, 2026
Reiterated: Buy
Price Target: ¥6,550 → ¥3,590
Current: ¥2,801
Upside: +28.17%
Novo Nordisk
Sep 22, 2026
Reiterated: Hold
Price Target: $42
Current: $39.43
Upside: +6.52%
Royalty Pharma
Sep 8, 2026
Rated: Buy
Price Target: $65 → $68
Current: $63.75
Upside: +6.67%
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40.00
Current: $32.98
Upside: +21.29%
Takeda Pharmaceutical Company
Jun 4, 2026
Reiterated: Buy
Price Target: $21
Current: $20.36
Upside: +3.14%
Coherus Oncology
May 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.05
Upside: -
Bausch Health Companies Inc.
Apr 30, 2026
Reiterated: Hold
Price Target: $9.95
Current: $9.09
Upside: +9.46%
Molecular Partners AG
Mar 16, 2026
Reiterated: Buy
Price Target: CHF 15.00
Current: CHF 3.03
Upside: +395.05%
Takeda Pharmaceutical Company Limited
May 21, 2025
Reiterated: Buy
Price Target: ¥5,135
Current: ¥6,364
Upside: n/a
Mar 14, 2025
Reiterated: Buy
Price Target: $17
Current: $3.61
Upside: n/a